The following are the objectives of Core B at The Ohio State University (OSU): (1) Synthesize sufficient quantities of selected natural products for more extensive biological evaluation, (2) Explore structure-activity relationships (SAR) and optimize pharmacological properties of highly promising agents through systematic modification of the natural product scaffold. All new compounds synthesized in these studies will be submitted for the bioassays proposed in Projects 1 and 3 and Core A, (3) Support the structural assignment of isolated natural products through chemical synthesis and/or semi-synthetic derivatization, as necessary, (4) Develop sensitive, selective, accurate and precise assays to quantify lead compounds in in vitro and in vivo biological matrices, (5) Characterize solubility, stability and metabolic profiles of lead compounds in dosing formulations and in vitro cell and enzyme preparations to support optimal formulation and derivatization, as necessary, and (6) Produce pilot plasma concentration-time profiles and determine protein and blood cell binding in mice for early estimation of pharmacokinetic properties for select compounds prior to entry into hollow fiber assays.

Public Health Relevance

The primary goal of Core B is to support the discovery, characterization and optimization of novel anticancer agents through the synthesis, structural modification, and evaluation of pharmacokinetic properties of lead compounds discovered in Projects 1-3 that demonstrate promising biological activity.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-C (O1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
United States
Zip Code
El-Elimat, Tamam; Raja, Huzefa A; Figueroa, Mario et al. (2015) Sorbicillinoid analogs with cytotoxic and selective anti-Aspergillus activities from Scytalidium album. J Antibiot (Tokyo) 68:191-6
Yong, Yeonjoong; Pan, Li; Ren, Yulin et al. (2014) Assay development for the discovery of semaphorin 3B inducing agents from natural product sources. Fitoterapia 98:184-91
Ren, Yulin; Yuan, Chunhua; Qian, Yanrong et al. (2014) Constituents of an extract of Cryptocarya rubra housed in a repository with cytotoxic and glucose transport inhibitory effects. J Nat Prod 77:550-6
Pan, Li; Woodard, John L; Lucas, David M et al. (2014) Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species. Nat Prod Rep 31:924-39
Deng, Youcai; Chu, Jianhong; Ren, Yulin et al. (2014) The natural product phyllanthusmin C enhances IFN-? production by human NK cells through upregulation of TLR-mediated NF-?B signaling. J Immunol 193:2994-3002
El-Elimat, Tamam; Raja, Huzefa A; Day, Cynthia S et al. (2014) Greensporones: resorcylic acid lactones from an aquatic Halenospora sp. J Nat Prod 77:2088-98
Pérez, Lynette Bueno; Still, Patrick C; Naman, C Benjamin et al. (2014) Investigation of Vietnamese plants for potential anticancer agents. Phytochem Rev 13:727-739
Ren, Yulin; Lantvit, Daniel D; Deng, Youcai et al. (2014) Potent cytotoxic arylnaphthalene lignan lactones from Phyllanthus poilanei. J Nat Prod 77:1494-504
Luo, Shangwen; Kang, Hahk-Soo; Krunic, Aleksej et al. (2014) Carbamidocyclophanes F and G with Anti-Mycobacterium tuberculosis Activity from the Cultured Freshwater Cyanobacterium Nostoc sp. Tetrahedron Lett 55:686-689
Bueno Pérez, Lynette; Pan, Li; Muñoz Acuña, Ulyana et al. (2014) Caeruleanone A, a rotenoid with a new arrangement of the D-ring from the fruits of Millettia caerulea. Org Lett 16:1462-5

Showing the most recent 10 out of 65 publications